Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Area of Science:

• Virology
• Molecular Biology
• Biotechnology

Background:

• Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) research is crucial for understanding and combating the COVID-19 pandemic.
• Studying the SARS-CoV-2 life cycle typically requires specialized high-containment laboratories (Biosafety Level 3).
• Existing methods like lentiviral pseudotyping have limitations in comprehensively studying viral dynamics.

Purpose of the Study:

• To introduce and validate a novel virus-like particle (VLP) system, termed SC2-VLP, for studying SARS-CoV-2.
• To provide a safer and more accessible alternative to traditional methods for SARS-CoV-2 research.
• To enable detailed investigation of multiple stages of the SARS-CoV-2 life cycle.

Main Methods:

• SC2-VLPs were generated by co-expressing SARS-CoV-2 structural proteins (M, N, E, S) and an RNA packaging signal in HEK-293T cells.
• A luciferase reporter fused to the T20 signal was employed for sensitive detection of viral particle production.
• The system was designed to mimic key viral processes including assembly, genome packaging, and egress.

Main Results:

• The SC2-VLP system accurately mimics critical stages of the SARS-CoV-2 life cycle.
• This method allows for sensitive and precise quantification of viral particle production.
• SC2-VLPs provide greater fidelity to the natural viral life cycle compared to traditional VLP systems.

Conclusions:

• The SC2-VLP method offers a powerful, accessible, and safer tool for SARS-CoV-2 research.
• This system overcomes the limitations of BSL-3 containment and lentiviral pseudotyping methods.
• SC2-VLPs represent a significant advancement for antiviral research and the development of therapeutic strategies against SARS-CoV-2.